午夜视频在线播放,久久久无码精品亚洲A片消消乐

香蕉91成人一区二区三区飘花,91精品人妻一区二区三区蜜桃,四川少妇BBw搡BBBB槡BBBB,国产成人91一区二区三区APP

<noscript id="ccccc"><optgroup id="ccccc"></optgroup></noscript>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

3d丰满少妇在线观看 | 少妇性BBB搡BBB爽爽爽影院 | 成人网站一区在线看 | 日本人成A片在线一区二区人人添人人澡人人爽人人澡 | 人人夸人人干人人爽人人操 | 久久久久久久久久久资源 | 午夜精品A片一二三区蜜臀欧美一区二区三欧A片直播 | 国产免费网站无码观看 | 国产一级A片毛毛天码美女视频 | 久久国产精品一区二区 | 91蜜桃樱花成人影院 | 欧美熟女AAAAA片 | AV第一福利大全导航 | 影音先锋在线观看资源网 | 中文字字幕在线中文 | 亚洲AV成人精品一区二区三区四区 | 红桃视频欧美日韩在线石榴 | 91人妻人人澡人人爽人人 | ,亚洲人成毛片在线播放 | 国产三级午夜理伦三级 | 插插女免费视频疯狂 | 在线观看亚洲视频 | 91免费国产在线观看 | 国产精品久久国产愉拍 | 成人av在线观看网站 | 少妇色诱commagnet | 台湾成人做爰A片免费看 | 久久AV秘一区二区三区水牛 | 国产毛片精品区色欲黄A片州产精无码久久久久久高潮 | 欧美老熟妇乱大交XXXXX | 亚洲视频在线观看一区 | AV无码秘蜜桃成人片玉蝶直播 | 久久成人影视白浆潮喷视频在线观看 | 国产人妻久久爽无码 | 路边撒尿一区二区三区 | 91精品国产成人 | av一区二区三区四区 | 男女啪啪视频喷水爆操桃香奈木 | 在线免费观看国产精品 | 91人人妻人人澡人人爽人人精品99 | 亚洲天堂av在线 |

<nav id="c0cc0"><code id="c0cc0"></code></nav>

<noscript id="c0cc0"></noscript>